|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-5-3
|
|
pubmed:abstractText |
Treatment of Parkinson's Disease (PD) has been attempted by others by transplanting either the patient's own adrenal medullary tissue or fetal substantia nigra into caudate or putamen areas. However, the difficulties inherent in using the patient's own adrenal gland, or the difficulty in obtaining human fetal tissue, has generated the need to find alternative methods.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antiparkinson Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Carbidopa,
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Plasma Membrane Transport...,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Levodopa,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Transport Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0188-4409
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
33-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10071423-Adrenal Medulla,
pubmed-meshheading:10071423-Antiparkinson Agents,
pubmed-meshheading:10071423-Brain,
pubmed-meshheading:10071423-Carbidopa,
pubmed-meshheading:10071423-Carrier Proteins,
pubmed-meshheading:10071423-Caudate Nucleus,
pubmed-meshheading:10071423-Cell Differentiation,
pubmed-meshheading:10071423-Cells, Cultured,
pubmed-meshheading:10071423-Child,
pubmed-meshheading:10071423-Chromaffin Cells,
pubmed-meshheading:10071423-Combined Modality Therapy,
pubmed-meshheading:10071423-Dopamine,
pubmed-meshheading:10071423-Dopamine Plasma Membrane Transport Proteins,
pubmed-meshheading:10071423-Female,
pubmed-meshheading:10071423-Glucose,
pubmed-meshheading:10071423-Humans,
pubmed-meshheading:10071423-Levodopa,
pubmed-meshheading:10071423-Magnetics,
pubmed-meshheading:10071423-Male,
pubmed-meshheading:10071423-Membrane Glycoproteins,
pubmed-meshheading:10071423-Membrane Transport Proteins,
pubmed-meshheading:10071423-Middle Aged,
pubmed-meshheading:10071423-Nerve Tissue Proteins,
pubmed-meshheading:10071423-Neurons,
pubmed-meshheading:10071423-Parkinson Disease,
pubmed-meshheading:10071423-Receptors, Dopamine,
pubmed-meshheading:10071423-Tomography, Emission-Computed,
pubmed-meshheading:10071423-Transplantation, Heterotopic,
pubmed-meshheading:10071423-Treatment Outcome
|
|
pubmed:articleTitle |
Transplant of cultured neuron-like differentiated chromaffin cells in a Parkinson's disease patient. A preliminary report.
|
|
pubmed:affiliation |
Departamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), México, D.F. drucker@servidor.unam.mx
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|
